Navigation Links
Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
Date:12/7/2008

in (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%).

About Millennium

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. ("Takeda", TSE: 4502) in May, 2008. The Company's research, development and commercialization activities are focused in oncology. Additional information about Millennium is available through its website, www.millennium.com.

(1) Evaluation of VELCADE, dexamethasOne, and Lenalidomide with or without cyclophosphamide Using Targeted Innovative ONcology strategies in the treatment of front-line multiple myeloma

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com.

    Contacts:
    Manisha Pai                   Karen Gobler
    (617) 551-7877                (617) 444-1392
    Manisha.Pai@mpi.com           Karen.Gobler@mpi.com


'/>"/>
SOURCE Millennium: The Takeda Oncology Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  The MEDevice San Diego Conference, ... an event dedicated to bringing medtech professionals together for ... topics affecting the industry today. This year,s conference will ... and opportunities facing today,s medtech professional in a fun, ... register for MEDevice San Diego, please visit: MEDeviceSD.com. ...
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015 ... and specialty medicine, continues to grow and add customers ... than 40% of the 62 CTSAs awarded by the ... clinical research information management. This is among the largest ... "Our presence in the CTSA community keeps growing ...
(Date:6/30/2015)... 30, 2015 Nortek Security & Control ... ) and a leader in the residential and ... it acquired mobile personal emergency response system (mPERS) ... Inc. Headquartered in ... mobile PERS products and cloud-based software platforms that ...
Breaking Medicine Technology:MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2Velos continues adding CTSA customers - 40% now use Velos products 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... WORTH, Texas, Aug. 26 Healthpoint today announced,that ... the effectiveness of a,widely prescribed enzymatic debriding agent ... study was prompted, in part, by clinical reports,of ... healing,properties associated with Collagenase SANTYL(R) Ointment.(1,2), "Given ...
... Inc.,(Nasdaq: XTNT ) today announced that the positive ... in the most recent issue of the,peer-reviewed journal, EuroIntervention. ... Stella, M.D., of University Medical Center Utrecht, Utrecht,The Netherlands ... clinical,sites across Europe., The one-year CUSTOM II trial, ...
Cached Medicine Technology:Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
(Date:6/30/2015)... New Port Richey, FL (PRWEB) , ... June 30, 2015 , ... ... heroin use nearly doubled from 2007 to 2013 while heroin-related deaths more than tripled ... their greatest drug threat (1). Novus Medical Detox Center , a leading Florida-based ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... According to ... received a $3.1 million grant to study how sensory stimuli can be used to ... emphasis on improving care for children with autism, will compare patient experience in a ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, a drug and ... size of its medical staff to further enhance its ability to treat addiction ... practitioners and physician assistants -- now totals 17, compared to 7 in 2013, ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... currently pending in a federal multidistrict litigation now underway in the U.S. District ... next monthly Status Conference. According to the Court’s calendar, that conference has now ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... Dr. ... primary care sports medicine physician. He specializes in the diagnosis and treatment of non-surgical ... and for the people who participate in recreational athletics and use exercise to stay ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5
... March 17 The Community Oncology Alliance (COA) ... Center in Selma, Alabama . That brings a total ... past several months --with the majority increasing from 2009 forward ... reimbursement for cancer care. Yet the current healthcare reform plans ...
... Melancon its 2010 Legislator of the Year. The award was presented March 17 during the 2010 PIA Federal Legislative Summit. , ... , , ... ... ...
... A person with fibromyalgia experiences daily pain all over their body. Even something as simple as a ... a video on the "Science of Fibromyalgia" as a resource to help people understand the underlying science behind ... ... , ...
... The Quantitative Analysis of Normal Tissue Effects in ... the International Journal of Radiation Oncology*Biology*Physics , ... Radiation Oncology (ASTRO) to update recommendations for the ... the relationship between dose/volume and clinical outcome is ...
... Heart and Stroke Foundation of Canada, the Canadian Stroke ... Congress brings together leading stroke experts to exchange ideas ... rehab, and recovery. The Congress takes place ... Pre-conference workshops take place on June 6. ...
... exact a high toll. Being overly cautious or dismissive in ... of people with diabetes. Diabetes patients who have ... higher mortality rate than those who feel comfortable seeking support. ... Dr. Paul Ciechanowski, associate professor of psychiatry and behavioral sciences ...
Cached Medicine News:Health News:Latest Cancer Clinic Closure in Selma, Alabama 2Health News:Latest Cancer Clinic Closure in Selma, Alabama 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 4Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 2Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 3Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 4Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 2Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 3Health News:ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects 2Health News:Difficulty trusting and reaching out to others may shorten diabetes patients' lives 2Health News:Difficulty trusting and reaching out to others may shorten diabetes patients' lives 3Health News:Difficulty trusting and reaching out to others may shorten diabetes patients' lives 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: